Catalent shares jump on merger talk

Swiss chemicals and life sciences company Lonza Group AG has offered to acquire U.S. drug delivery technology company Catalent Inc, sources say.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.